tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Alaunos Therapeutics Inc

TCRT
Add to Watchlist
1.880USD
0.0000.00%
Close 07-31 16:00（ET）Quotes delayed by 15 min
4.42MMarket Cap
LossP/E TTM

Alaunos Therapeutics Inc

1.880
0.0000.00%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

TCRT Financials

See Alaunos Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Alaunos Therapeutics Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.52/--
Revenue / Forecast
0.00/--
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
5.00K
-50.00%
EPS(YoY)
-2.14
26.65%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
22.95%-0.52
17.15%-0.38
24.57%-0.53
91.17%-0.63
36.21%-0.67
90.54%-0.46
86.71%-0.70
-29.36%-7.10
83.30%-1.05
20.32%-4.90
---5.30
---5.49
---6.29
---6.15
---19.93
----
----
----
----
----
Revenue
-100.00%0.00
-25.00%3.00K
--0.00
-100.00%0.00
100.00%2.00K
300.00%4.00K
--0.00
0.00%4.00K
--1.00K
-90.91%1.00K
-100.00%0.00
--4.00K
----
--11.00K
631.41%2.91M
----
----
--0.00
--398.00K
----
Net Profit
6.24%-1.01M
-20.35%-893.00K
-2.84%-1.16M
6.91%-1.05M
36.21%-1.07M
90.54%-742.00K
86.70%-1.13M
87.13%-1.13M
83.26%-1.68M
14.37%-7.84M
4.24%-8.48M
11.67%-8.77M
-2.66%-10.05M
22.34%-9.16M
61.07%-8.85M
56.19%-9.93M
54.59%-9.79M
48.21%-11.79M
-11.90%-22.73M
-21.91%-22.67M
Net Margin
----
-60.47%-29766.67%
----
----
68.10%-53650.00%
97.63%-18550.00%
----
87.13%-28225.00%
---168200.00%
-841.95%-784300.00%
----
---219325.00%
----
---83263.64%
---981.48%
----
----
----
----
----
Gross Margin
----
0.00%100.00%
----
----
0.00%100.00%
0.00%100.00%
----
0.00%100.00%
--100.00%
0.00%100.00%
----
--100.00%
----
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
-100.00%0.00%
-100.00%0.00%
--0.00%
--0.00%
--22.59%
--25.82%
--33.66%
----
----
----
----
----
Income Statement
Revenue
-100.00%0.00
-25.00%3.00K
--0.00
-100.00%0.00
100.00%2.00K
300.00%4.00K
--0.00
0.00%4.00K
--1.00K
-90.91%1.00K
-100.00%0.00
--4.00K
----
--11.00K
631.41%2.91M
----
----
--0.00
--398.00K
----
Operating profit
7.33%-1.01M
-20.13%-907.00K
-3.22%-1.19M
10.89%-1.04M
37.31%-1.09M
77.53%-755.00K
84.10%-1.15M
85.83%-1.17M
81.99%-1.74M
60.57%-3.36M
12.46%-7.23M
12.16%-8.23M
-6.46%-9.67M
17.36%-8.52M
62.94%-8.26M
58.63%-9.37M
57.87%-9.09M
54.72%-10.31M
-9.72%-22.30M
-21.68%-22.64M
Net Profit
6.24%-1.01M
-20.35%-893.00K
-2.84%-1.16M
6.91%-1.05M
36.21%-1.07M
90.54%-742.00K
86.70%-1.13M
87.13%-1.13M
83.26%-1.68M
14.37%-7.84M
4.24%-8.48M
11.67%-8.77M
-2.66%-10.05M
22.34%-9.16M
61.07%-8.85M
56.19%-9.93M
54.59%-9.79M
48.21%-11.79M
-11.90%-22.73M
-21.91%-22.67M
Balance Sheet
Current assets
-9.09%970.00K
-27.84%1.99M
-24.37%2.69M
-20.09%3.74M
-82.33%1.07M
-66.65%2.75M
-72.41%3.55M
-75.09%4.68M
-84.19%6.04M
-84.64%8.26M
-76.81%12.87M
-69.40%18.78M
-45.27%38.18M
-31.75%53.80M
-42.51%55.51M
-31.37%61.36M
-38.10%69.77M
-39.63%78.83M
-37.74%96.55M
-48.37%89.41M
Total current liabilities
-43.97%595.00K
17.49%813.00K
11.50%921.00K
18.41%1.07M
-14.35%1.06M
-64.62%692.00K
-82.34%826.00K
-82.05%907.00K
-92.73%1.24M
-91.91%1.96M
-85.77%4.68M
-81.13%5.05M
-19.64%17.06M
50.65%24.17M
16.67%32.87M
96.98%26.77M
11.99%21.23M
-12.67%16.04M
45.82%28.17M
-20.56%13.59M
Total assets
-11.18%1.88M
7.66%2.97M
4.90%3.72M
1.22%4.74M
-64.88%2.12M
-66.66%2.75M
-81.74%3.55M
-83.25%4.68M
-87.59%6.04M
-87.28%8.26M
-71.13%19.44M
-62.23%27.93M
-42.77%48.64M
-31.55%64.94M
-40.80%67.34M
-30.75%73.93M
-33.84%84.99M
-35.18%94.86M
-31.42%113.76M
-41.23%106.77M
Total liabilities
-43.97%595.00K
17.49%813.00K
11.50%921.00K
18.41%1.07M
-14.35%1.06M
-64.62%692.00K
-85.09%826.00K
-85.55%907.00K
-93.52%1.24M
-92.59%1.96M
-84.28%5.54M
-81.40%6.28M
-46.67%19.13M
-28.33%26.38M
-21.80%35.23M
82.60%33.75M
57.11%35.87M
64.59%36.81M
114.79%45.05M
1.20%18.48M
Total equity
21.74%1.29M
4.36%2.15M
2.90%2.80M
-2.92%3.66M
-77.94%1.06M
-67.29%2.06M
-80.40%2.72M
-82.58%3.77M
-83.74%4.80M
-83.64%6.31M
-56.72%13.90M
-46.12%21.65M
-39.93%29.51M
-33.59%38.55M
-53.26%32.11M
-54.49%40.18M
-53.50%49.12M
-53.17%58.06M
-52.59%68.71M
-45.98%88.28M
Cash Flow Statement
Net operating income
-33.55%-1.03M
6.76%-552.00K
-8.07%-844.00K
58.30%-701.00K
59.73%-772.00K
91.98%-592.00K
87.75%-781.00K
75.99%-1.68M
79.57%-1.92M
-3.58%-7.38M
-3.73%-6.37M
14.47%-7.00M
-20.73%-9.38M
52.86%-7.13M
35.84%-6.14M
61.84%-8.19M
49.26%-7.77M
11.21%-15.13M
40.39%-9.58M
-53.16%-21.45M
Net investment
----
---1.00K
---97.00K
----
----
-100.00%0.00
-100.00%0.00
100.00%0.00
100.00%0.00
1716.13%1.50M
107.14%1.00K
-136.84%-135.00K
20.69%-23.00K
74.09%-93.00K
96.22%-14.00K
96.96%-57.00K
95.96%-29.00K
90.47%-359.00K
81.61%-370.00K
46.17%-1.88M
Net financing
----
--0.00
--0.00
--3.26M
----
--0.00
--0.00
100.00%0.00
100.00%0.00
-100.00%0.00
100.00%0.00
---11.98M
---6.16M
4655.91%8.47M
-108.45%-2.11M
-100.00%0.00
-100.00%0.00
-146.50%-186.00K
92218.52%24.93M
58.33%19.00K

FAQs

What is the total revenue of Alaunos Therapeutics Inc?

According to Alaunos Therapeutics Inc's FY2025 earnings report, its total revenue reached 5.00K, with a year-on-year change of 10.00K.

What are the current assets of Alaunos Therapeutics Inc?

According to Alaunos Therapeutics Inc's FY2025 earnings report, its current assets were 1.99M, with a year-on-year change of -27.84.

What are the total assets of Alaunos Therapeutics Inc?

According to Alaunos Therapeutics Inc's FY2025 earnings report, its total assets of Alaunos Therapeutics Inc were 2.97M, with a year-on-year change of 7.66.

What are the total liabilities of Alaunos Therapeutics Inc?

According to Alaunos Therapeutics Inc's FY2025 earnings report, its total liabilities of Alaunos Therapeutics Inc were 813.00K, with a year-on-year change of 17.49.

What is the total equity of Alaunos Therapeutics Inc?

According to Alaunos Therapeutics Inc's FY2025 earnings report, its total equity of Alaunos Therapeutics Inc was 2.15M, with a year-on-year change of 4.36.

What is the net operating income of Alaunos Therapeutics Inc?

According to Alaunos Therapeutics Inc's FY2025 earnings report, its net operating income of Alaunos Therapeutics Inc was -4.22M, with a year-on-year change of 12.20.

What is the Earnings Per Share (EPS) of Alaunos Therapeutics Inc?

According to Alaunos Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.14, with a year-on-year change of 26.65.

What is the net income of Alaunos Therapeutics Inc?

According to Alaunos Therapeutics Inc's FY2025 earnings report, its net income was -4.18M, with a year-on-year change of 10.75.

What is the net margin of Alaunos Therapeutics Inc?

According to Alaunos Therapeutics Inc's FY2025 earnings report, its net profit margin was -83520.00, with a year-on-year change of -78.50.

What is the Return on Equity (ROE) of Alaunos Therapeutics Inc?

According to Alaunos Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -198.10, with a year-on-year change of -77.19.

What is the Return on Assets (ROA) of Alaunos Therapeutics Inc?

According to Alaunos Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -145.99, with a year-on-year change of -71.89.

What is the operating profit of Alaunos Therapeutics Inc?

According to Alaunos Therapeutics Inc's FY2025 earnings report, its operating profit was -4.22M, with a year-on-year change of 12.20.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy